Pharmacogenetic Warfarin Dose Refinements Remain Significantly Influenced by Genetic Factors after One Week of Therapy

INTRODUCTION: By guiding initial warfarin dose, pharmacogenetic (PGx) algorithms may improve the safety of warfarin initiation. However, once INR response is known, the contribution of PGx to dose refinements is uncertain. This study sought to develop and validate clinical and PGx dosing algorithms...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Horne, Benjamin D., Lenzini, Petra A., Wadelius, Mia, Jorgensen, Andrea L., Kimmel, Stephen E., Ridker, Paul M., Eriksson, Niclas, Anderson, Jeffrey L., Pirmohamed, Munir, Limdi, Nita A., Pendleton, Robert C., McMillin, Gwendolyn A., Burmester, James K., Kurnik, Daniel, Stein, C. Michael, Caldwell, Michael D., Eby, Charles S., Rane, Anders, Lindh, Jonatan D., Shin, Jae-Gook, Kim, Ho-Sook, Angchaisuksiri, Pantep, Glynn, Robert J., Kronquist, Kathryn E., Carlquist, John F., Grice, Gloria R., Barrack, Robert L., Li, Juan, Gage, Brian F.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2011
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3292349/
https://ncbi.nlm.nih.gov/pubmed/22186998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1160/TH11-06-0388
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak